Lv4
540 积分 2024-06-11 加入
IMpower150 Final Overall Survival Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC
19小时前
求助中
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial
17天前
已完结
How the bone microenvironment shapes the pre-metastatic niche and metastasis
25天前
已完结
Matrix stiffening and acquired resistance to chemotherapy: concepts and clinical significance
1个月前
已完结
Targeting Tumor Physical Microenvironment for Improved Radiotherapy
1个月前
已完结
Metabolic landscape of disseminated cancer dormancy
1个月前
已完结
Managing Resistance to Immune Checkpoint Inhibitors in Lung Cancer: Treatment and Novel Strategies
1个月前
已完结
Increased perfluorooctanoic acid accumulation facilitates the migration and invasion of lung cancer cells via remodeling cell mechanics
1个月前
已完结
Metabolic landscape of disseminated cancer dormancy
1个月前
已完结
The transcriptional landscape and mutational profile of lung adenocarcinoma
1个月前
已完结
皖公网安备34019202002308
